Contact this trialFirst, we need to learn more about you.
Anti-malarial drug
Hydroxychloroquine + Mesalamine for Ulcerative Colitis
Recruiting1 awardPhase 1 & 2
Atlanta, Georgia
This trial is testing whether Hydroxychloroquine, when combined with Mesalamine, is effective in reducing clinical and histologic disease activity in patients with active mild to severe Ulcerative Colitis. The trial will also assess the immunological effects of hydroxychloroquine in this population.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.